Americas Hernia Society Quality Collaborative Foundation

What it reported doing in 2020

Program #3-provide industry reports: ahsqc foundation provides hernia device makers with access to data from the patient data registry in the following report formats (collectively, industry reports): (i) benchmark comparison reports that summarize all collaborative-wide data in the data registry (e.g., volume of surgeries sorted by wound class, mesh type, or mesh location) (global reports); (ii) benchmark comparison reports that compare the quality and outcomes of a particular device against all similar devices on an aggregated, de-identified basis (company specific reports); and (iii) benchmark comparison reports that address specific product or quality improvement questions of interest to the device maker (custom reports)-these reports are of increasing interest to device makers for their regulatory interactions with the fda and other medical device regulatory bodies. The global reports are not unique to any industry user, while the company specific reports and custom reports are unique to a particular user. The global reports and the company specific reports are generated using a template developed by ahsqc foundation, and will require little selection services, while the custom reports will be generated on a more individualized basis and require more selection services. Custom reports are similar to the reports provided to participating surgeons and certain academic researchers without charge to support their research and publication efforts. Ahsqc foundation generates the industry reports using the same methodology and services that have been established for the collaborative-wide benchmark comparison reports that it generates for other collaborative activities. The industry reports use the same identical de-identified database that is available to all other data users, and present the data in a manner substantially similar to other collaborative-wide reports that are available to all other data users (e.g., use of a subset of clinical data by a surgeon or researcher). Other data users, and present the data in a manner substantially similar to other collaborative-wide reports that are available to all other data users (e.g., use of a subset of clinical data by a surgeon or researcher).

Financial Efficiency

• Mission deployment rate: 100%; rating input score 100
• Program expense ratio: 87.4%; rating input score 87
• Fundraising efficiency: $40.07 raised per $1 spent on fundraising; rating input score 71; 71st percentile among comparable filings

Transparency & Controls

• Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
• Pay-setting controls: Limited
• Foreign activity oversight: Limited
• Grant itemization coverage: 99.7%; rating input score 100; 46th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Limited

Accountability

• Independent voting board: 77.8%; rating input score 78; 15th percentile among comparable filings
• Governance controls: 3 of 8 controls in place; rating input score 38
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Fail
  • Document-retention policy: Fail
  • CEO compensation review process: Fail
  • Other executive compensation review process: NotApplicable
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Missing
  • Independent financial-statement audit: Fail

Sustainability

• Operating margin: -70.7%; rating input score 2; 2nd percentile among comparable filings
• Total-asset coverage ratio: 0; rating input score 0; 0th percentile among comparable filings
• Liabilities to assets ratio: Limited
• Officer compensation ratio: 8.3%; rating input score 46; 46th percentile among comparable filings

Growth

• Program expense growth: 32.1% per year; rating input score 100; 93rd percentile among comparable filings
• Revenue growth: 24.7% per year; rating input score 100; 90th percentile among comparable filings
• Asset growth: 14.4% per year; rating input score 100; 72nd percentile among comparable filings